Difference between revisions of "Template:Lipid modifying agents"
Jump to navigation
Jump to search
imported>Whywhenwhohow (add Ezetimibe/rosuvastatin) |
imported>Anypodetos (Bempedoic acid approved now) |
||
| Line 55: | Line 55: | ||
| group4 = [[ATP citrate lyase]] inhibitors ([[Low-density lipoprotein|LDL]]) | | group4 = [[ATP citrate lyase]] inhibitors ([[Low-density lipoprotein|LDL]]) | ||
| list4 = | | list4 = | ||
| − | * [[Bempedoic acid]] | + | * [[Bempedoic acid]] |
}} | }} | ||
Revision as of 12:25, 22 February 2020
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Lipid modifying agents|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Lipid modifying agents|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Lipid modifying agents|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.